MRI-Targeted Prostate Biopsy: What Radiologists Should Know

Area of Science:

• Urology
• Radiology
• Oncology

Background:

• Transrectal ultrasound (TRUS)-guided systematic biopsy is the standard for prostate cancer detection but has low sensitivity for clinically significant cancer.
• Multiparametric MRI has improved prostate cancer diagnosis, increasing the relevance of targeted biopsy techniques.
• Targeted biopsies like MRI-TRUS fusion and in-bore MRI-guided biopsy show higher detection rates for clinically significant prostate cancer.

Purpose of the Study:

• To enhance understanding of MRI-guided prostate biopsy techniques.
• To provide guidance for safe and effective performance of these advanced biopsy methods.
• To maximize the diagnostic yield of prostate cancer detection using modern imaging and biopsy approaches.

Main Methods:

• Review of diagnostic multiparametric MRI utilization.
• Explanation of MRI-TRUS fusion biopsy principles and procedures.
• Description of direct (in-bore) MRI-guided biopsy techniques.

Main Results:

• MRI-guided targeted biopsies demonstrate superior detection rates for clinically significant prostate cancer compared to TRUS-guided systematic biopsy.
• These advanced techniques are increasingly used, particularly in cases with high clinical suspicion despite negative initial biopsies.
• Upfront diagnostic MRI is driving the adoption of targeted biopsies, potentially supplanting routine systematic biopsies.

Conclusions:

• MRI-guided biopsy techniques offer improved sensitivity for clinically significant prostate cancer.
• These advanced methods are becoming integral to prostate cancer diagnostics.
• Safe and effective implementation of MRI-guided biopsies is crucial for maximizing diagnostic accuracy.